President Trump Signs Executive Order to Accelerate Psychedelic Research and Access By Watertime - April 18, 2026 1 Post Content RELATED ARTICLESMORE FROM AUTHOR Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy